RT Journal Article
SR Electronic
T1 Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Biopsies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.12.20229658
DO 10.1101/2020.11.12.20229658
A1 Ray, Animesh
A1 Jain, Deepali
A1 Agarwal, Shubham
A1 Swaroop, Shekhar
A1 Goel, Ayush
A1 Das, Prasenjit
A1 Arava, Sudheer Kumar
A1 Mridha, Asit Ranjan
A1 Nambirajan, Aruna
A1 Singh, Geetika
A1 Arulselvi, S.
A1 Mathur, Purva
A1 Kumar, Sanchit
A1 Sahni, Shubham
A1 Nehra, Jagbir
A1 Nazneen,
A1 BM, Mouna
A1 Rastogi, Neha
A1 Mahato, Sandeep
A1 Gupta, Chaavi
A1 Bharadhan, S
A1 Dhital, Gaurav
A1 Goel, Pawan
A1 Pandey, Praful
A1 KN, Santosh
A1 Chaudhary, Shitij
A1 Keri, Vishakh C
A1 Chauhan, Vishal Singh
A1 Mahishi, Niranjan
A1 Shahi, Anand
A1 R, Ragu
A1 Gupta, Baidnath K
A1 Aggarwal, Richa
A1 Soni, Kapil Dev
A1 Nischal, Neeraj
A1 Soneja, Manish
A1 Lalwani, Sanjeev
A1 Sarkar, Chitra
A1 Guleria, Randeep
A1 Wig, Naveet
A1 Trikha, Anjan
YR 2020
UL http://medrxiv.org/content/early/2020/11/16/2020.11.12.20229658.abstract
AB Background The Covid-19 pandemic began in China in December 2019. India is the second most affected country, as of November 2020 with more than 8.5million cases. Covid-19 infection primarily involves the lung with severity of illness varying from influenza-like illness to acute respiratory distress syndrome. Other organs have also found to be variably affected. Studies evaluating the histopathological changes of Covid-19 are critical in providing a better understanding of the disease pathophysiology and guiding treatment. Minimally invasive biopsy techniques (MITS/B) provide an easy and suitable alternative to complete autopsies. In this prospective single center study we present the histopathological examination of 37 patients who died with complications of Covid-19.Methods This was an observational study conducted in the Intensive Care Unit of JPN Trauma Centre AIIMS. A total of 37 patients who died of Covid-19 were enrolled in the study. Post-mortem percutaneous biopsies were taken by the help of surface landmarking/ultrasonography guidance from lung, heart, liver, and kidneys; after obtaining ethical consent. The biopsy samples were then stained with haematoxylin and eosin stain. Immunohistochemistry (IHC) was performed using CD61 and CD163 in all lung cores. SARS-CoV-2 virus was detected using IHC with primary antibodies in selected samples. Details regarding demographics, clinical parameters, hospital course, treatment details, and laboratory investigations were also collected for clinical correlation.Results A total of 37 patients underwent post-mortem minimally invasive tissue sampling. Mean age of the patients was 48.7years and 59.5% of them were males. Respiratory failure was the most common complication seen in 97.3%. Lung histopathology showed acute lung injury and diffuse alveolar damage in 78% patients. Associated bronchopneumonia was seen in 37.5% patients and scattered microthrombi were visualised in 21% patients. Immunostaining with CD61 and CD163 highlighted megakaryocytes, and increased macrophages in all samples. Immunopositivity for SARS-CoV-2 was observed in Type II pneumocytes. Acute tubular injury with epithelial vacuolization was seen in 46% of the renal biopsies but none of them showed evidence of microvascular thrombosis. 71% of the liver tissue cores showed evidence of Kupfer cell hyperplasia. 27.5% had evidence of submassive hepatic necrosis and 14% had features of acute on chronic liver failure. All the heart biopsies showed non-specific features such as hypertrophy with nucleomegaly with no evidence of myocardial necrosis in any of the samples.Conclusions The most common finding in this cohort is the diffuse alveolar damage with demonstration of SARS-CoV-2 protein in the acute phase of DAD. Microvascular thrombi were rarely identified in the lung, liver and kidney. Substantial hepatocyte necrosis, hepatocyte degeneration, Kupffer cell hypertrophy, micro, and macrovesicular steatosis unrelated to microvascular thrombi suggests that liver might be a primary target of Covid-19. This study highlights the importance of MITS/B in better understanding the pathological changes associated with Covid-19.Competing Interest StatementThe authors have declared no competing interest.Funding Statementfunding was received from AIIMS intramural research fundAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the AIIMS Institute Ethics Committee (Ref No: IEC-536/05.06.2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data presented in the manuscript are available offline and can be referred to if necessary.